Detalhe da pesquisa
1.
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
N Engl J Med
; 387(14): 1279-1291, 2022 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36112399
2.
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
N Engl J Med
; 386(21): 2011-2023, 2022 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-35544369
3.
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.
N Engl J Med
; 387(18): 1673-1687, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36260859
4.
Interim report of the reactogenicity and immunogenicity of SARS-CoV-2 XBB-containing vaccines.
J Infect Dis
; 2024 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38349280
5.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med
; 385(19): 1774-1785, 2021 Nov 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34551225
6.
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials.
Clin Infect Dis
; 76(2): 271-280, 2023 01 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36130187
7.
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial.
J Infect Dis
; 226(10): 1731-1742, 2022 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35535503
8.
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
N Engl J Med
; 387(13): 1234-1236, 2022 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36083119
9.
Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination.
N Engl J Med
; 387(23): 2194-2196, 2022 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36416761
10.
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge.
N Engl J Med
; 385(26): 2485-2487, 2021 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34731553
11.
Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
Lipids Health Dis
; 14: 45, 2015 May 19.
Artigo
Inglês
| MEDLINE | ID: mdl-25985907
12.
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
Nat Commun
; 14(1): 5125, 2023 08 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37612300
13.
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results.
Nat Med
; 29(9): 2325-2333, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37653342
14.
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.
Lancet Infect Dis
; 23(9): 1007-1019, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37348519
15.
Intestinal sterol transporters and cholesterol absorption inhibition.
Curr Opin Lipidol
; 22(6): 467-78, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22101558
16.
mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children.
medRxiv
; 2022 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-35118475
17.
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.
Nat Med
; 28(4): 823-830, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35145311
18.
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
Nat Med
; 27(12): 2224-2233, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34887572
19.
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge.
medRxiv
; 2021 Sep 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34611666
20.
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.
J Clin Lipidol
; 13(6): 997-1007.e8, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31629703